• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用肿瘤坏死因子(TNF)-α抑制剂成功治疗类脂质渐进性坏死及相关视网膜血管炎。

Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor.

作者信息

Panse Ketaki, Herrera Manuela, Fung Maxwell, Brassard Alain, Moussa Kareem

机构信息

Department of Ophthalmology & Vision Science, University of California, Davis, Sacramento, CA, USA.

University of California, Davis, School of Medicine, Sacramento, CA, USA.

出版信息

Am J Ophthalmol Case Rep. 2023 Jul 26;32:101908. doi: 10.1016/j.ajoc.2023.101908. eCollection 2023 Dec.

DOI:10.1016/j.ajoc.2023.101908
PMID:37560554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10407115/
Abstract

PURPOSE

To report the clinical and histopathologic features of necrobiosis lipoidica and associated retinal vasculitis and describe successful treatment of both skin and eye manifestations with adalimumab, a tumor necrosis factor (TNF)-alpha inhibitor.

OBSERVATIONS

A 35-year-old patient with bipolar disorder and ocular hypertension was referred for evaluation of bilateral retinal vasculitis. Fluorescein angiography revealed bilateral occlusive retinal vasculitis. Physical exam was notable for multiple annular and round erythematous hyperpigmented and atrophic patches and plaques on both lower extremities. Skin biopsy revealed a diagnosis of necrobiosis lipoidica, a rare granulomatous skin disease. Both the patient's retinal vasculitis and skin patches responded favorably to treatment with adalimumab, a TNF-alpha inhibitor.

CONCLUSIONS AND IMPORTANCE

This case highlights the importance of obtaining a complete history and physical exam in patients who present with ocular inflammation, as extraocular manifestations of disease may be present. It also demonstrates the effectiveness of a multidisciplinary approach to evaluation and management of these patients, as both skin and eye involvement were successfully treated with adalimumab, a TNF-alpha inhibitor.

摘要

目的

报告类脂质渐进性坏死及相关视网膜血管炎的临床和组织病理学特征,并描述使用肿瘤坏死因子(TNF)-α抑制剂阿达木单抗成功治疗皮肤和眼部表现的情况。

观察结果

一名患有双相情感障碍和高眼压的35岁患者因双侧视网膜血管炎接受评估。荧光素血管造影显示双侧闭塞性视网膜血管炎。体格检查发现双下肢有多个环形和圆形红斑色素沉着和萎缩性斑片及斑块。皮肤活检诊断为类脂质渐进性坏死,一种罕见的肉芽肿性皮肤病。患者的视网膜血管炎和皮肤斑片对TNF-α抑制剂阿达木单抗治疗反应良好。

结论与意义

该病例强调了对出现眼部炎症的患者进行完整病史和体格检查的重要性,因为可能存在疾病的眼外表现。它还证明了多学科方法对这些患者进行评估和管理的有效性,因为皮肤和眼部受累均通过TNF-α抑制剂阿达木单抗成功治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/732626c81aae/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/a62e1ae9e231/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/446b94fc7ac8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/b3f22a187722/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/a58a0de11ba5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/ef43b5280666/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/904286c97af5/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/732626c81aae/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/a62e1ae9e231/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/446b94fc7ac8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/b3f22a187722/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/a58a0de11ba5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/ef43b5280666/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/904286c97af5/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cd0c/10407115/732626c81aae/gr7.jpg

相似文献

1
Successful treatment of necrobiosis lipoidica and associated retinal vasculitis with tumor necrosis factor (TNF)-alpha inhibitor.使用肿瘤坏死因子(TNF)-α抑制剂成功治疗类脂质渐进性坏死及相关视网膜血管炎。
Am J Ophthalmol Case Rep. 2023 Jul 26;32:101908. doi: 10.1016/j.ajoc.2023.101908. eCollection 2023 Dec.
2
The role of anti-tumour necrosis factor in wound healing: A case report of refractory ulcerated necrobiosis lipoidica treated with adalimumab and review of the literature.抗肿瘤坏死因子在伤口愈合中的作用:阿达木单抗治疗难治性溃疡性类脂质渐进性坏死的病例报告及文献综述
SAGE Open Med Case Rep. 2019 Oct 18;7:2050313X19881594. doi: 10.1177/2050313X19881594. eCollection 2019.
3
[Successful treatment of a patient with ulcerated necrobiosis lipoidica non diabeticorum with adalimumab].[用阿达木单抗成功治疗一名非糖尿病性溃疡性类脂质渐进性坏死患者]
Hautarzt. 2013 Jul;64(7):509-11. doi: 10.1007/s00105-013-2535-z.
4
Necrobiosis Lipoidica Diabeticorum: A pediatric case report.糖尿病性类脂质渐进性坏死:一例儿科病例报告。
Dermatoendocrinol. 2014 Jan 1;6(1):e27790. doi: 10.4161/derm.27790. Epub 2014 Jan 17.
5
Bilateral retinal vasculitis associated with cold agglutinin disease treated with obinutuzumab and infliximab.用奥妥珠单抗和英夫利昔单抗治疗的与冷凝集素病相关的双侧视网膜血管炎。
Am J Ophthalmol Case Rep. 2022 Nov 12;28:101752. doi: 10.1016/j.ajoc.2022.101752. eCollection 2022 Dec.
6
Systemic Lupus Erythematosus-associated Retinal Vasculitis Treated with Adalimumab.系统性红斑狼疮相关性视网膜血管炎用阿达木单抗治疗。
Ocul Immunol Inflamm. 2022 May 19;30(4):981-985. doi: 10.1080/09273948.2020.1828937. Epub 2020 Nov 16.
7
Selective case study describing the use of Apligraf on necrobiosis lipoidica associated with diabetes.描述使用Apligraf治疗与糖尿病相关的类脂质渐进性坏死的选择性病例研究。
J Wound Care. 2014 Feb;23(2):S12-5. doi: 10.12968/jowc.2014.23.Sup2a.S12.
8
Necrobiosis Lipoidica.类脂质渐进性坏死
Dermatol Clin. 2015 Jul;33(3):343-60. doi: 10.1016/j.det.2015.03.003.
9
Xanthoma-like Skin Changes in an Elderly Woman with a Normal Lipid Profile.脂质谱正常的老年女性的黄瘤样皮肤改变
Acta Dermatovenerol Croat. 2017 Jul;25(2):167-169.
10
Atypical presentation of necrobiosis lipoidica in a pediatric patient.一名儿科患者的类脂质渐进性坏死的非典型表现。
Pediatr Dermatol. 2019 Jan;36(1):e31-e33. doi: 10.1111/pde.13716. Epub 2018 Dec 2.

引用本文的文献

1
Shedding Light on Photodynamic Therapy in the Treatment of Necrobiosis Lipoidica: A Multicenter Real-Life Experience.探讨光动力学疗法治疗类脂质渐进性坏死:多中心真实世界经验。
Int J Mol Sci. 2024 Mar 23;25(7):3608. doi: 10.3390/ijms25073608.

本文引用的文献

1
A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus.糖尿病患者血糖控制与糖尿病性脂性渐进性坏死关系的系统评价。
Int J Dermatol. 2017 Dec;56(12):1319-1327. doi: 10.1111/ijd.13610. Epub 2017 Jun 26.
2
Adalimumab in Patients with Active Noninfectious Uveitis.阿达木单抗治疗活动性非感染性葡萄膜炎患者的疗效。
N Engl J Med. 2016 Sep 8;375(10):932-43. doi: 10.1056/NEJMoa1509852.
3
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial.
阿达木单抗预防皮质类固醇控制的非感染性活动性葡萄膜炎患者的葡萄膜炎发作(VISUAL II):一项多中心、双盲、随机、安慰剂对照的 3 期临床试验。
Lancet. 2016 Sep 17;388(10050):1183-92. doi: 10.1016/S0140-6736(16)31339-3. Epub 2016 Aug 16.
4
The course of retinal vasculitis.视网膜血管炎的病程。
Br J Ophthalmol. 2014 Jun;98(6):785-9. doi: 10.1136/bjophthalmol-2013-303443. Epub 2014 Feb 7.
5
Treatment of pre-ulcerative necrobiosis lipoidica with infliximab.英夫利昔单抗治疗脂膜炎性溃疡前期坏死。
Acta Derm Venereol. 2011 Sep;91(5):587-8. doi: 10.2340/00015555-1117.
6
Necrobiosis lipoidica and inflammatory eye disease.类脂质渐进性坏死与炎性眼病。
JRSM Short Rep. 2011 Feb 10;2(2):9. doi: 10.1258/shorts.2011.010097.
7
The pathology and pathogenesis of retinal vasculitis.视网膜血管炎的病理学与发病机制。
Neuropathol Appl Neurobiol. 2003 Aug;29(4):325-40. doi: 10.1046/j.1365-2990.2003.00499.x.
8
Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases.糖尿病性类脂质渐进性坏死。171例临床与病理研究。
Arch Dermatol. 1966 Mar;93(3):272-81. doi: 10.1001/archderm.93.3.272.
9
Diabetes mellitus, sarcoidosis,?necrobiosis lipoidica.糖尿病、结节病、类脂质渐进性坏死。
Proc R Soc Med. 1969 Apr;62(4):350. doi: 10.1177/003591576906200421.
10
Resolution of necrobiosis lipoidica with exclusive clobetasol propionate treatment.仅用丙酸氯倍他索治疗脂性渐进性坏死的消退情况。
J Am Acad Dermatol. 1990 May;22(5 Pt 1):855-6. doi: 10.1016/s0190-9622(08)81185-1.